Error: Could not add to watchlist. X
+ Watchlist

Dendreon Corp

DNDN:US
Ticker Change
DNDN:US has changed to a new ticker symbol
USD
Volume
0
Previous Close
0.13
Volume
0
Previous Close
0.13
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer.
Address
1301 2nd Avenue
Seattle, WA 98101
United States
Phone
1-206-256-4545
Show More